Precision Medicine and Personalized Health
28. September 2018 | Campus Biotech, Genf
Nach dem Erfolg der FEAM Conference 2016 fand am 28. September 2018 die zweite Konferenz der Federation of European Academies of Medicine (FEAM) in der Schweiz statt. Gegen 200 Teilnehmer/innen aus 28 Ländern waren der Einladung von FEAM und SAMW gefolgt, um in Genf jüngste Entwicklungen zum Thema «Precision Medicine and Personalized Health» zu diskutieren. Als Tagungspartner begleitete SantéPerSo die Veranstaltung.
Nationale und internationale Expertinnen und Experten beleuchteten das Gebiet der Personalisierten Gesundheit aus verschiedenen Blickwinkeln: Forschungsstand und klinische Anwendungen, nationale und internationale Netzwerke waren genauso im Fokus wie ethische, gesellschaftliche und rechtliche Rahmenbedingungen.
Im Vorfeld der FEAM Conference fanden auf dem Campus Biotech in Genf zwei thematisch verwandte Veranstaltungen statt: die 4-tägige ESPT Summer School zum Thema «Precision Medicine & Personalised Health» für achtzig junge Forschende aus ganz Europa, gemeinsam organisiert von der European Society of Pharmacogenomics and Personalised Therapy (ESPT) und vom Swiss Personalized Health Network (SPHN). Zudem führte das FEAM European Biomedical Policy Forum einen runden Tisch zu «Precision Medicine and Personalized Health» durch.
Programm, Bericht und Präsentationen
Programme FEAM Conference 2018
Summary Report FEAM Conference 2018
Prof. Ron H. N. van Schaik, European Society of Pharmacogenomics and Personalised Therapy (ESPT) President
Report from the ESPT/SPHN Summer School
Prof. Peter J. Meier-Abt, Swiss Personalized Health Network (SPHN) President
Report from the FEAM Forum Round Table
Denis Horgan, European Alliance for Personalised Medicine, Brussels, BE
Prof. Tim Hubbard, Genomics England and Department of Medical and Molecular Genetics, King's College, London, UK
From the 100,000 Genomes Project to the UK NHS Genome Medicine Service
Prof. Jaak Vilo, Institute of Computer Science, University of Tartu, EE
Prof. Nan Shen, Ren ji Hospital, Shanghai Jiao Tong University School of Medicine, CN
Prof. Stylianos Antonarakis, Department of Genetic Medicine and Development, University of Geneva, CH
Genomics and Big Data: from Science to Health Care and back
Prof. Younglun Luo, Department of Biomedicine, Aarhus University, DK
and Lars Bolund Institute of Regenerative Medicine, BGI-Qingdao, CN
Towards Personalized Regenerative Cell Therapy
Prof. Christophe Le Touneau, Department of Drug Development and Innovation, Curie Institute, Paris, FR
Clinical Utility of Precision Medicine in Oncology
Prof. Amalio Telenti, The Scripps Research Institute, La Jolla, US
Human Metabolome as an Approach to Personalized Medicine
Prof. Jan Albert Kuivenhoven, Department of Pediatrics, University Medical Center Groningen, NL
From Rare to Common Disease: from Genetics to Therapy
Prof. Dan M. Roden, Vanderbilt University Medical Center, Nashville, US
Implementation of Pharmacogenomics in Clinical Medicine in the US
Prof. Maja Krajinovic, CHU-Sainte-Justine, Montreal, CA
Pharmacogenomics in Pediatric Hemato-Oncology
Prof. Munir Pirmohamed, Institute of Translational Medicine, University of Liverpool, UK
Pharmacogenomics of Adverse Drug Reactions
Dr. Thorsten Gutjahr, Companion Diagnostics, AstraZeneca, Cambridge, UK
Precision Medicine and Genomics: a Pharma Perspective
Prof. Marc Van den Bulcke, Sciensano, Brussels, BE
Perspectives for Public Health Genomics within a Health Care System Context
Prof. Ernst Hafen, Institute of Molecular Systems Biology, ETH Zurich, CH
Data to the People: MIDATA Cooperatives
Prof. Joshua Hordern, Faculty of Theology and Religion, University of Oxford, UK
Ethical Imperatives for Personalized Medicine